hs-10541

KRAS G12C Mutation Advanced Solid Tumor

Jiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1

—

Rating in progress

hs-10541 in KRAS G12C Mutation Advanced Solid Tumor is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active